U.K. doctors to trial ibuprofen in coronavirus patients with severe symptoms

There are questions around whether ibuprofen, a non-steroidal anti-inflammatory medicine, may help or worsen COVID-19 symptoms.

There are questions around whether ibuprofen, a non-steroidal anti-inflammatory medicine, may help or worsen COVID-19 symptoms.

Getty Images

British doctors are trialing a formulation of anti-inflammatory ibuprofen to see if it reduces respiratory failure in patients with severe symptoms of COVID-19.

The trial involves a particular formulation of ibuprofen, which researchers said had been shown to be more effective than standard ibuprofen for treating severe acute respiratory distress syndrome (ARDS), a complication of COVID-19.

The formulation is already licensed for use in Britain for other conditions.

“If successful, the global public health value of this trial result would be immense given the low cost and availability of this medicine,” said Matthew Hotopf, director of NIHR Maudsley Biomedical Research Centre.

The trial, known as “LIBERATE,” will be a randomized study, with recruitment of up to 230 patients expected over the coming months.

It is being run by Guy’s & St Thomas’ NHS Foundation Trust in London, King’s College London (KCL) and pharmaceutical organization the SEEK Group.

Trending Stories

  • Young brothers, 6 and 7, die in crash after taking grandparents’ car

  • George Floyd: What we know about the arrest, video and investigation

In March, France’s health minister said people should not use anti-inflammatory drugs such as ibuprofen if they have symptoms of COVID-19, the disease caused by the new coronavirus.

[ Sign up for our Health IQ newsletter for the latest coronavirus updates ]

However, U.S., British and European Union drug regulators as well as Reckitt Benckiser, which makes Nurofen, have all said there is no evidence that ibuprofen makes COVID-19 worse.

Mitul Mehta, director of KCL’s Centre for Innovative Therapeutics, said that possible well-known gastric side effects from ibuprofen meant that paracetamol was better to relieve COVID-19 symptoms in its early stages.

But he added there was no evidence to back up the French claims that ibuprofen worsens COVID-19 symptoms, saying the formulation being used in the trial should lessen the possible side effects.

“There’s no way these early reports would’ve been talking about this different formulation,” Mehta told Reuters.

“The trial is the right forum in which to test the side effects and to test the efficacy.”

Related news

Mueller defends Russia probe, says Roger Stone ‘remains a convicted felon, and rightly so’.

The op-ed in The Washington Post marked Mueller's first public statement on his investigation since his congressional appearance last July.

Coronavirus: Trump wears face mask for first time during a public appearance.

As he left the White House, he told reporters: "When you're in a hospital, especially ... I think it's expected to wear a mask."

Donald Trump Wears Face Mask In Public For First Time.

US President Donald Trump wore a face mask in public for the first time Saturday, finally yielding to intense pressure to set a public health example as the coronavirus rampages across America.

Historic 249-year-old California church devastated by fire.

Fire alarms at the San Gabriel Mission rang around 4 a.m., and when firefighters responded to the historic structure they saw smoke rising from the wooden rooftop.

1 223

Thousands of Israelis protest Netanyahu’s handling of coronavirus pandemic.

With economic stress deepening in recent weeks, many Israelis think the government has not done enough to compensate hundreds of thousands of workers who lost their jobs as a result of restrictions and shutdowns.

1 9

By continuing to browse World News (UAZMI), you acknowledge that you have read the Terms of Use and agree to the use of cookies